Gloshell
成分辞典

成分辞典

C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONS

Solvent naphtha (petroleum) heavy aromatic.

定義

Solvent naphtha (petroleum) heavy aromatic. A complex combination of hydrocarbons obtained from distillation of aromatic streams. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C12-15

化粧品での役割

他の成分を溶かす基剤SOLVENT

安全性・規制情報

韓国の有害物質GHS分類なし · 既存化学物質

出典: 韓国 有害物質GHS情報(環境公団)

Other restriction: ban substances that deplete the ozone layer

出典: EU CosIng 成分リスト

詳しい資料 — 表示名・識別番号・物性・試験記録・文献

別名・識別情報

C12-15 ALKANE/CYCLOALKANE/AROMATIC HYDROCARBONSINCIC12-15알케인/사이클로알케인/아로마틱하이드로카본韓国の表示名(食薬処標準名)Solvent naphtha (petroleum), heavy arom.別名
CAS No.化学物質登録番号
64742-94-5
EC No.EU化学物質目録番号
265-198-5
DTXSID米国EPA化学物質番号
DTXSID9028251

製品が実際に使っている用途

米国EPAにこの成分を届け出た製品36件の用途です。化粧品以外の製品も含まれるため、上の数行がこの成分の主な使い道といえます。

  • Solvent16
  • Processing aids not otherwise specified4
  • Lubricating agent4
  • Binder2
  • Surfactant (surface active agent)2
  • Defoamer2
  • Fuel agents2
  • Viscosity modifier1
その他の用途 3件
  • Dispersing agent1
  • Fuel1
  • Demulsifier1

出典: 米国EPA CompTox

刺激・感作試験の記録

皮膚試験15件・眼試験8件の記録があります。

刺激が強いと分類12件中程度と分類1件低いと分類18件

試験ごとに結論が分かれています(最も多い結論の割合 39%)。この成分が刺激性だとは言い切れないということです。 原料そのものを試験した記録で、完成品に含まれる濃度での刺激性とは異なります。

試験23件をすべて見る
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs 44054-44093 according to
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to EPA OTS 798.4100 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs. 44054-44093
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: EPA guidelines in FR Vol. 44, No. 145, pgs 44054-44093
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation) equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
  • Not likely to be sensitizing
    skin sensitisation: in vivo (non-LLNA) · Screening · according to EPA OTS 798.4100 (Skin Sensitisation)
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Severe Irritation
    skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to
  • Category 2
    Skin Irritation · Screening
  • Severe Irritation
    skin irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · EPA OTS 798.4470 (Acute Dermal Irritation) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
  • Classification not possible
    Skin Sensitization · Screening
  • Studies Indicate No Significant Irritation
    skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · EPA OTS 798.4500 (Acute Eye Irritation) according to
  • Category 2
    Eye Irritation · Screening
  • Studies Indicate No Significant Irritation
    eye irritation: in vivo · Screening · other guideline: EPA Guidelines in FR Vol. 44, No. 145, pgs. 44054-44093 according to

出典: 米国EPA CompTox

連携データベース 8